Insider · CIK 0001186836
Robert S Tissue
Files at BHRB (Burke & Herbert Financial Services Corp.). First filing -, latest -.
In brief
Robert S Tissue files SEC Form 4 as officer at BHRB (Burke & Herbert Financial Services Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert S Tissue has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | BHRB Burke & Herbert Financial Services Corp. | MOption exercise Common Stock | +8,684 | $43.33 | $376k | 62,542 | Aug 3, 2026 |
| Jul 30, 2026 | BHRB Burke & Herbert Financial Services Corp. | MOption exercise Common Stock | +8,436 | $52.29 | $441k | 70,978 | Aug 3, 2026 |
| Jul 30, 2026 | BHRB Burke & Herbert Financial Services Corp. | FTax withholding Common Stock | -12,914 | $73.63 | $951k | 58,064 | Aug 3, 2026 |
| Jul 30, 2026 | BHRB Burke & Herbert Financial Services Corp. | MOption exercise Stock Settled Appreciation Rightsderivative | -8,684 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Jul 30, 2026 | BHRB Burke & Herbert Financial Services Corp. | MOption exercise Stock Settled Appreciation Rightsderivative | -8,436 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Jul 17, 2026 | BHRB Burke & Herbert Financial Services Corp. | MOption exercise Common Stock | +8,599 | $47.47 | $408k | 59,525 | Jul 20, 2026 |
| Jul 17, 2026 | BHRB Burke & Herbert Financial Services Corp. | MOption exercise Common Stock | +4,110 | $51.58 | $212k | 63,635 | Jul 20, 2026 |
| Jul 17, 2026 | BHRB Burke & Herbert Financial Services Corp. | FTax withholding Common Stock | -9,777 | $72.85 | $712k | 53,858 | Jul 20, 2026 |
| Jul 17, 2026 | BHRB Burke & Herbert Financial Services Corp. | MOption exercise Stock Settled Appreciation Rightsderivative | -8,599 | $0.00 | $0 | 0 | Jul 20, 2026 |
| Jul 17, 2026 | BHRB Burke & Herbert Financial Services Corp. | MOption exercise Stock Settled Appreciation Rightsderivative | -4,110 | $0.00 | $0 | 0 | Jul 20, 2026 |
| May 3, 2026 | BHRB Burke & Herbert Financial Services Corp. | FTax withholding Common Stock | -1,364 | $64.64 | $88k | 50,926 | May 4, 2026 |
| Jan 22, 2026 | BHRB Burke & Herbert Financial Services Corp. | AGrant or award Common Stock | +1,550 | $0.00 | $0 | 52,290 | Feb 19, 2026 |
| Jan 22, 2026 | BHRB Burke & Herbert Financial Services Corp. | AGrant or award Common Stock | +3,080 | $0.00 | $0 | 50,740 | Jan 23, 2026 |
| May 3, 2025 | BHRB Burke & Herbert Financial Services Corp. | FTax withholding Common Stock | -464 | $57.39 | $27k | 47,660 | May 6, 2025 |
| Jan 23, 2025 | BHRB Burke & Herbert Financial Services Corp. | AGrant or award Common Stock | +4,620 | $0.00 | $0 | 38,275 | Jan 27, 2025 |
Questions about Robert S Tissue
Answered from the filings on this page, as of the latest one.
Is Robert S Tissue buying or selling?
Robert S Tissue has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert S Tissue's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert S Tissue has 0.
Where does Robert S Tissue file Form 4?
Robert S Tissue has filed Form 4 at BHRB (Burke & Herbert Financial Services Corp.) as EVP, Balance Sheet Strategy. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.